The new automated TGS COVID-19 IgM assay is now available!
To order the automated TGS COVID-19 IgM or IgG assays, or the ErbaLisa® COVID-19 IgM or IgG ELISA assays please contact your local sales support team:
Or your local sales representative:
|Germany Customer Service
Tel: +49 69 26019 0960
|France Customer Service
Tel: +33 1 40 77 04 60
|UK Customer Service
Tel: +44 (0) 191 519 6155
|Product name||Code||Product Type||Description|
|TGS COVID-19 lgG||CVCL100G||Automated||100 Tests|
|TGS COVID-19 IgM||CVCL100M||Automated||100 Tests|
|TGS COVID-19 Control Set||CVCLCSGM||Automated||2 Level|
|ErbaLisa® COVID-19 IgG||IME00136||Manual||96 Well|
|ErbaLisa® COVID-19 IgM||IME00137||Manual||96 Well|
TGS COVID-19 IgM assay
The COVID-19 IgM assay, a product of our partnership with Technogenetics, is designed to run on our IDS-iSYS Multi-Discipline Automated System, to reduce testing time and meet demand associated with SARS-CoV-2 antibody testing, providing a fast and efficient test with a high degree of sensitivity and specificity.
Why choose our assay for SARS-CoV-2 antibodies?
All steps of the COVID-19 IgM serology assay are automated with no manual reagent preparation required, ensuring minimal hands-on time for lab staff, and a high daily throughput with first results available within 35 minutes.
We offer 2 separate kits for anti-SARS-CoV-2 IgG and anti-SARS-CoV-2 IgM that can run at the same time, from the same sample tube. The distinction of the antibody class is a clinical advantage compared to total antibody assays to confirm an early or ancient infection. Moreover, a follow-up of the sero-conversion from IgM to IgG is possible.
Our tests offer a combined sensitivity of 100% and specificity of 98.6%, when used together, for samples collected from patients between 15 to 30 days after the onset of symptoms.
IDS-iSYS Multi-Discipline Automated Analyser
The IDS-iSYS is a unique compact, benchtop instrument based on Chemiluminescence and Absorbency technology. As a fully automated solution, the IDS-iSYS provides quality and efficiency throughout the complete testing process. The IDS-iSYS has on board refrigeration, ready to use reagents, continuous loading, batch and STAT functionality and is easy to operate with auto start-up and shut-down functionality. For more information about our IDS-iSYS, click here.
Our ELISA offering
The ErbaLisa® COVID-19 IgM ELISA is an in vitro diagnostic test intended for the detection of IgM antibodies to SARS-CoV-2 (COVID-19), whereas the ErbaLisa® COVID-19 IgG ELISA is an in vitro diagnostic test intended for the detection of IgG antibodies to SARS-CoV-2 (COVID-19); both assays are for use with human serum samples.
The ErbaLisa® COVID-19 IgG and IgM ELISAs are among the quickest ELISA kits available boasting a total incubation time of only 50 minutes. With the incorporation of ready to use reagents, ensuring minimal hands-on time for staff and room temperature incubations, the assay is simple to adopt within the laboratory. The assay was developed with consideration to its suitability in any size laboratory due to its compatibility with open platform ELISA systems.
*Diagnostic sensitivity of the test was calculated across 58 samples drawn from symptomatic Italian patients in March and April 2020. For blood samples taken 15 to 30 days after onset of symptoms, combined diagnostic sensitivity was 100% (all samples positive). The diagnosis of SARS-CoV-2 infection of those patients was confirmed in nasopharyngeal swab samples by RT-PCR, specific for the SARS-CoV-19 virus
Initial data demonstrated an overall combined diagnostic specificity of 98.6%, with 352 of 357 presumptive negative samples testing negative with the test. These negative samples came from both pre-epidemic blood donors, as well as routine laboratory samples taken during the epidemic, some with influenza or other potentially interfering pathologies.